{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:14Z","timestamp":1784751854957,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.drugalcdep.2014.12.037","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T02:30:58Z","timestamp":1422325858000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Quetiapine for the treatment of cocaine use disorder"],"prefix":"10.1016","volume":"149","author":[{"given":"Andre","family":"Tapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Ernst","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sylvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nael","family":"Kilzieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0005","first-page":"CD003352","article-title":"Dopamine agonists for the treatment for cocaine dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0010","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1176\/appi.ajp.2009.08121811","article-title":"Randomized, double-blind, placebo-controlled trial of Vigatrin for the treatment of cocaine dependence in Mexican parolees","volume":"166","author":"Brodie","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1034\/j.1399-5618.2002.02229.x","article-title":"Quetiapine in bipolar disorder and cocaine dependence","volume":"4","author":"Brown","year":"2002","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0020","first-page":"CD007380","article-title":"Efficacy of psychostimulant drugs for cocaine dependence","author":"Castells","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-004-2010-8","article-title":"Risperidone diminishes cocaine-induced craving","volume":"178","author":"De La Garza","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1360-0443.2002.00209.x","article-title":"Pharmacological treatment of cocaine dependence: a systematic review","volume":"97","author":"de Lima","year":"2002","journal-title":"Addiction"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.12.037_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1360-0443.2005.00986.x","article-title":"Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence","volume":"100","author":"Elkashef","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1037\/0022-006X.68.1.134","article-title":"The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties","volume":"68","author":"Fals-Stewart","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0376-8716(99)00114-3","article-title":"Significant interaction between clozapine and cocaine in cocaine addicts","volume":"59","author":"Farren","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbr.2009.11.029","article-title":"Quetiapine blocks cocaine-induced enhancement of brain stimulation reward","volume":"208","author":"Gallo","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00004714-200006000-00003","article-title":"Risperidone for the treatment of cocaine dependence: randomized, double-blind trial","volume":"20","author":"Grabowski","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/10550490802544318","article-title":"Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial","volume":"18","author":"Hamilton","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-011-2231-6","article-title":"Aripiprazole maintenance increases smoked cocaine self-administration in humans","volume":"216","author":"Haney","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0075","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jamapsychiatry.2013.2295","article-title":"Topiramate for the treatment of cocaine addiction","volume":"70","author":"Johnson","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0376-8716(03)00009-7","article-title":"A pilot trial of olanzapine for the treatment of cocaine dependence","volume":"70","author":"Kampman","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib9095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2013.05.026","article-title":"A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence","volume":"133","author":"Kampman","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0376-8716(00)00193-9","article-title":"Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity","volume":"63","author":"Kampman","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/JCP.0b013e318166f50d","article-title":"Quetiapine for the treatment of cocaine dependence: an open-label trial","volume":"28","author":"Kennedy","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.4088\/JCP.13r08525","article-title":"Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"74","author":"Kishi","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1530-0277.2011.01649.x","article-title":"A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients","volume":"36","author":"Litten","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.psc.2012.03.012","article-title":"Psychostimulant treatment of cocaine dependence","volume":"35","author":"Mariani","year":"2012","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0120","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.biopsych.2012.05.032","article-title":"Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial","volume":"72","author":"Mariani","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(97)01351-4","article-title":"Olanzapine attenuates the reinforcing effects of cocaine","volume":"340","author":"Meil","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0130","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2174\/138161211796150783","article-title":"Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study","volume":"17","author":"Meini","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0135","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.jcp.0000138763.23482.2a","article-title":"Quetiapine for treatment of alcohol dependence","volume":"24","author":"Monnelly","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-1781(01)00255-4","article-title":"Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine","volume":"102","author":"Newton","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0150","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4088\/JCP.v69n0808","article-title":"Do atypical antipsychotics effectively treat co-occuring bipolar disorder and stimulant dependence? A randomized, double-blind trial","volume":"69","author":"Nejtek","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0155","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4088\/JCP.v66n1011","article-title":"Reduction of opioid-withdrawal symptoms with quetiapine","volume":"66","author":"Pinkofsky","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib9155","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1185\/030079906X112561","article-title":"Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial","volume":"22","author":"Potvin","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.12.037_bib0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.2005.00990.x","article-title":"A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10\/L-carnitine for the treatment of cocaine dependence","volume":"100","author":"Reid","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib9165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1037\/a0030992","article-title":"Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use","volume":"28","author":"Robinson","year":"2014","journal-title":"Psychol Addict Behav."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1521-0391.1998.tb00473.x","article-title":"Risperidone, ERG and cocaine craving","volume":"7","author":"Roy","year":"1998","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0175","first-page":"452","article-title":"Potential benefits of quetiapine in the treatment of substance dependence disorders","volume":"29","author":"Sattar","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0180","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4088\/JCP.v64n1207","article-title":"Randomized placebo-controlled trial of baclofen for cocaine dependence, preliminary effects for individuals with chronic patterns of cocaine use","volume":"64","author":"Shoptaw","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fpsyt.2012.00077","article-title":"Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation","volume":"3","author":"Schmitz","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0195","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1177\/070674379704200920","article-title":"Risperidone diminishes cue-elicited craving in withdrawn cocaine-dependent patients","volume":"42","author":"Smelson","year":"1997","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2004.03.009","article-title":"A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients","volume":"27","author":"Smelson","year":"2004","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0205","series-title":"Measuring Alcohol Consumption","first-page":"41","article-title":"Timeline follow-back a technique for assessing self-reported alcohol consumption","author":"Sobell","year":"1992"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0210","first-page":"304","article-title":"The Brief Substance Craving Scale\u2014measuring craving in clinical trials","volume":"180","author":"Somoza","year":"2000","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib9210","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jamapsychiatry.2013.872","article-title":"A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence","volume":"70","author":"Somoza","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-008-1069-z","article-title":"Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice","volume":"199","author":"Sorensen","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2014.12.037_bib0220","article-title":"Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings","author":"Substance Abuse and Mental Health Services Administration","year":"2013"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615000241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615000241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:45:18Z","timestamp":1566261918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615000241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":46,"alternative-id":["S0376871615000241"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.12.037","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quetiapine for the treatment of cocaine use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.12.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}